These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 12186123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
    Hurtado R, Candelaria M, Majluf-Cruz A, Sosa-Camas RE, Labardini-Méndez J.
    Rev Invest Clin; 1994; 46(1):59-61. PubMed ID: 8079066
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
    Góra-Tybor J, Krykowski E, Robak T.
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):255-8. PubMed ID: 9017166
    [Abstract] [Full Text] [Related]

  • 5. G-CSF and the management of clozapine-induced agranulocytosis.
    Gerson SL.
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():139-42. PubMed ID: 7525542
    [Abstract] [Full Text] [Related]

  • 6. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.
    Sprikkelman A, de Wolf JT, Vellenga E.
    Leukemia; 1994 Dec; 8(12):2031-6. PubMed ID: 7528854
    [Abstract] [Full Text] [Related]

  • 7. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
    Andrès E, Maloisel F, Zimmer J.
    Br J Haematol; 2010 Jul; 150(1):3-8. PubMed ID: 20151980
    [Abstract] [Full Text] [Related]

  • 8. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 9. [Hematopoietic growth factors as supportive treatment in drug-induced agranulocytosis].
    Hospers GA, de Wolf JT, Hazenberg BP, Vellenga E.
    Ned Tijdschr Geneeskd; 1993 Oct 16; 137(42):2152-4. PubMed ID: 7694163
    [Abstract] [Full Text] [Related]

  • 10. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
    Andrès E, Maloisel F.
    Curr Opin Hematol; 2008 Jan 16; 15(1):15-21. PubMed ID: 18043241
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of methimazole-induced agranulocytosis with granulocyte-macrophage colony stimulating factor].
    Somogyi A, Werling K, Rosta A, Láng I.
    Orv Hetil; 1994 Nov 06; 135(45):2483-5. PubMed ID: 7991239
    [Abstract] [Full Text] [Related]

  • 12. [Agranulocytosis induced by synthetic antithyroid drugs: efficacy of hematopoietic growth factors].
    Genet P, Pulik M, Lionnet F, Bremont C.
    Ann Endocrinol (Paris); 1994 Nov 06; 55(1):39-42. PubMed ID: 7528487
    [Abstract] [Full Text] [Related]

  • 13. Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
    Wu HH, Talpaz M, Champlin RE, Pilat SR, Kurzrock R.
    Cancer; 2003 Dec 01; 98(11):2410-9. PubMed ID: 14635076
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis.
    Nand S, Bayer R, Prinz RA, Felten W, Godwin JE.
    Am J Hematol; 1991 Aug 01; 37(4):267-9. PubMed ID: 1858785
    [Abstract] [Full Text] [Related]

  • 15. Long-term outcome of patients treated with hematopoietic growth factors for idiosyncratic drug-induced agranulocytosis.
    Andrès E, Noel E, Maloisel F.
    Am J Med; 2004 Mar 01; 116(5):354. PubMed ID: 14984824
    [No Abstract] [Full Text] [Related]

  • 16. Carbimazole-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor--a case report.
    Ng SC.
    Ann Acad Med Singap; 1995 May 01; 24(3):465-6. PubMed ID: 7574435
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hematopoietic growth factors as supportive treatment in agranulocytosis as a result of administered drugs].
    te Gussinklo JT.
    Ned Tijdschr Geneeskd; 1994 Jan 08; 138(2):98. PubMed ID: 7906401
    [No Abstract] [Full Text] [Related]

  • 19. Sargramostim for sulfasalazine-induced agranulocytosis.
    Rospond RM, Glowacki RC, Mailliard JA.
    Clin Pharm; 1993 Mar 08; 12(3):179. PubMed ID: 8098278
    [No Abstract] [Full Text] [Related]

  • 20. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 08; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.